NEW YORK, Aug 17: Taking tamoxifen is tied to a sharply reduced risk of a second breast cancer among women who carry the BRCA1 or BRCA2 “breast cancer genes,” new research shows. Women with mutations of those genes are much more likely to develop breast and ovarian cancer than other women. Some – like Angelina Jolie – will opt to have their breasts removed preemptively, which reduces breast cancer risk by more than 95 percent. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel